RI
RPRX icon

Ridgewood Investments’s Royalty Pharma RPRX Stock Holding History

Ridgewood Investments’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,555
Closed -$219K – 219
2026
Q1 		$219K Buy
+4,555
New +$199K 0.09% 202
2025
Q3 		$296K Sell
8,397
-15
-0.2% -$543 0.13% 182
2025
Q2 		$303K Sell
8,412
-11,236
-57% -$372K 0.13% 165
2025
Q1 		$612K Sell
19,648
-11,087
-36% -$351K 0.29% 99
2024
Q4 		$784K Buy
30,735
+8,913
+41% +$236K 0.38% 81
2024
Q3 		$617K Sell
21,822
-2,620
-11% -$72.6K 0.31% 94
2024
Q2 		$645K Sell
24,442
-602
-2% -$16.7K 0.32% 94
2024
Q1 		$761K Buy
25,044
+120
+0.5% +$3.54K 0.4% 78
2023
Q4 		$700K Sell
24,924
-863
-3% -$23.7K 0.41% 84
2023
Q3 		$700K Buy
25,787
+4,267
+20% +$127K 0.46% 75
2023
Q2 		$662K Buy
21,520
+14,175
+193% +$480K 0.38% 79
2023
Q1 		$265K Buy
7,345
+1,975
+37% +$73.2K 0.16% 146
2022
Q4 		$212K Sell
5,370
-302
-5% -$12.6K 0.15% 173
2022
Q3 		$228K Sell
5,672
-276
-5% -$11.8K 0.19% 151
2022
Q2 		$250K Sell
5,948
-12,852
-68% -$527K 0.2% 149
2022
Q1 		$732K Sell
18,800
-249
-1% -$9.78K 0.48% 69
2021
Q4 		$759K Buy
19,049
+543
+3% +$21.1K 0.48% 73
2021
Q3 		$669K Buy
18,506
+2,860
+18% +$111K 0.45% 74
2021
Q2 		$641K Buy
15,646
+10,223
+189% +$435K 0.41% 88
2021
Q1 		$237K Buy
+5,423
New +$257K 0.15% 168

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ridgewood Investments's RPRX Position: Q2 2026 in Review

Ridgewood Investments sold out of Royalty Pharma (RPRX) in Q2 2026, closing a stake of 4,555 shares — an estimated $219K sold.

Ridgewood Investments first reported a position in RPRX in Q1 2021 and held it in 20 quarters. The position peaked at $784K in Q4 2024. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Ridgewood Investments reported no remaining Royalty Pharma position as of Q2 2026 after selling out during the quarter.
  • Ridgewood Investments sold 4,555 Royalty Pharma shares in Q2 2026, an estimated $219K.
  • Ridgewood Investments first reported a position in Royalty Pharma in Q1 2021 and held it in 20 quarters.
  • Ridgewood Investments's Royalty Pharma position peaked at $784K in Q4 2024.
  • 641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Ridgewood Investments's 13F filing for Q2 2026, filed 3 Aug 2026.